Shortfalls in pediatric hydrocephalus clinical outcome analysis

Mohammad Sami Walid1, Joe Sam Robinson

  • 1Georgia NeuroCenter, Medical Center of Central Georgia, 777 Hemlock Street, Macon, GA 31201, USA. mswalid@yahoo.com

Insights

Child hydrocephalus treatment costs have significantly increased, while patient discharges decreased. The literature shows a plateau in research, with few studies on cost analysis or high-level evidence.

Area of Science:

  • Pediatric Neurosurgery
  • Health Economics
  • Medical Informatics

Background:

  • Childhood hydrocephalus presents significant treatment challenges.
  • Understanding treatment outcomes and costs is crucial for healthcare management.
  • Literature analysis can reveal trends in research and clinical practice.

Purpose of the Study:

  • To analyze trends in child hydrocephalus treatment costs and literature.
  • To assess the volume and focus of research on pediatric hydrocephalus.
  • To evaluate cost awareness in the scientific literature concerning hydrocephalus.

Main Methods:

  • Utilized Nationwide Inpatient Sample (NIS) data to extract hospital charges for pediatric hydrocephalus treatment.
  • Employed PubMed search engine to probe biomedical literature on child hydrocephalus.
  • Analyzed trends in aggregate hospital charges, patient discharges, and publication volume over 13-15 years.

Main Results:

  • Aggregate hospital charges for ventriculo-peritoneal shunting in children under 18 increased 1.7-fold to $235.6 million by 2009.
  • Hospital discharges decreased by 25.5% over 13 years.
  • Literature on child hydrocephalus increased 1.6-fold, but randomized controlled trials (0.94%) and cost analysis papers (0.77%) remain scarce.

Conclusions:

  • Research on pediatric hydrocephalus has plateaued, with a concerning lack of high-grade clinical evidence (RCTs).
  • There is a significant gap in the literature regarding cost analysis and economic considerations for hydrocephalus treatment.
  • Increased focus on cost-effectiveness and robust clinical trials is needed for managing childhood hydrocephalus.
Abstract